Is neffy effective for allergic reactions?

See the DrugPatentWatch profile for neffy

Is neffy effective for allergic reactions?
Yes. Neffy is the first epinephrine nasal spray approved by the FDA for emergency treatment of allergic reactions, including anaphylaxis. Clinical studies showed it produced blood levels of epinephrine similar to those achieved with traditional injections, confirming the drug reaches therapeutic concentrations quickly enough to reverse symptoms in most patients.

How does neffy work compared with an injection?
Neffy delivers epinephrine through the nasal mucosa, where it is absorbed directly into the bloodstream. This route bypasses the need for a needle while still raising blood pressure, relaxing airway muscles, and reducing swelling—actions identical to those of an injected dose. Because absorption occurs rapidly, the onset of effect is comparable to that of an intramuscular shot.

What do the clinical trials show?
In pivotal studies, a single 2 mg dose of neffy raised blood epinephrine concentrations within minutes and produced measurable increases in heart rate and blood pressure that matched or exceeded those seen with 0.3 mg intramuscular epinephrine. These changes occurred fast enough to meet FDA criteria for treating anaphylaxis. The same trials reported that most participants experienced only mild, short-lived nasal irritation.

Who makes neffy and when does its patent protection end?
ARS Pharmaceuticals developed neffy. The product’s key patents covering the nasal-spray formulation and delivery device are listed on DrugPatentWatch.com; the earliest listed expiry is 2035, giving the company roughly a decade of market exclusivity before generic versions can be approved.

Can neffy be used for all types of allergic reactions?
Neffy is indicated for any allergic reaction that would normally require an epinephrine injection, including food-induced anaphylaxis, insect-sting reactions, and medication allergies. It is not approved for mild skin rashes or isolated hives without breathing or circulatory symptoms.

What side effects are patients asking about?
Reported side effects include brief nasal discomfort, runny nose, sneezing, and throat irritation. These effects typically resolve within minutes and are considered acceptable trade-offs for avoiding an injection. No serious adverse events linked to the nasal route were observed in the registration trials.

What happens if symptoms return after the first dose?
Current labeling instructs patients to seek emergency medical help immediately after using neffy. If symptoms persist or return, a second dose may be given in the opposite nostril, following the same instructions used for repeat epinephrine injections.